Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 915121 | ISIN: CA3759161035 | Ticker-Symbol: VGA
München
17.01.25
08:03 Uhr
48,000 Euro
+0,200
+0,42 %
Branche
Bekleidung/Textil
Aktienmarkt
S&P/TSX 60
1-Jahres-Chart
GILDAN ACTIVEWEAR INC Chart 1 Jahr
5-Tage-Chart
GILDAN ACTIVEWEAR INC 5-Tage-Chart
RealtimeGeldBriefZeit
48,40048,60017.01.
48,40048,60017.01.
ACCESS Newswire
562 Leser
Artikel bewerten:
(2)

Gildan Activewear: Gildan Donates Surgical Equipment to Mario Catarino Rivas Hospital

Finanznachrichten News

NORTHAMPTON, MA / ACCESSWIRE / April 9, 2024 / Gildan, a leading apparel manufacturer, is pleased to share that it has donated advanced surgical equipment, valued at over U.S. $230,000, to the newly renovated pediatric operating room at the Mario Catarino Rivas regional hospital (HMCR) today, supporting children in northern and western Honduras who have been awaiting surgery. This donation contributes to making healthcare more accessible to children and communities in Honduras.

Gildan committed to this in-kind investment in collaboration with the Honduran Pediatric Association, Valle de Sula Chapter (APHCVS), who identified the urgent need for surgeries among hundreds of Honduran children. The donated equipment will benefit children requiring surgery, and within its first six months of use, is expected to help reduce Catarino Rivas hospital's backlog of operations by 50%.

With the new equipment in place, the pediatric operating room is now equipped to treat infants weighing less than one pound, as well as children of any age in need of surgery, including those requiring highly complex, precise, or delicate procedures across various pediatric specialties such as urology, pulmonology, otolaryngology, and endoscopy.

The equipment donated includes:

  • An anesthesia machine featuring highly specialized computerized systems designed to deliver oxygen, anesthesia, and other gases safely, tailored to the child's age, weight, and height. The machine includes a carbon dioxide detector to monitor intubation, a gas delivery mechanism that effectively ventilates the patient similar to what is done in an intensive care unit; a neuromuscular relationship monitor to facilitate precise medication; and a sedation level monitor to indicate the depth of anesthesia, thus safeguarding the patient's brain. These features assist surgeons in making informed decisions during surgery, contributing to successful outcomes.
  • A pediatric stretcher designed with flexibility and articulation to accommodate children of any age comfortably, correctly, and safely during surgical interventions.
  • A Holmium laser utilizing minimally invasive light energy, enabling surgeons to perform more precise and delicate surgeries without causing thermal damage to nearby tissues. This technology ensures more accurate surgeries with fewer postoperative complications.

"Gildan is committed to supporting the health and well-being of Honduran children," says Claudia Sandoval, Vice-President, Global Social Compliance and Environmental Affairs at Gildan. "Thanks to this donation, more families, especially from the regions of Cortés, Comayagua, Copán, Lempira, Colón, Atlántida, Santa Bárbara, Ocotepeque, and Intibucá, have access to the appropriate pediatric surgical infrastructure that they urgently need."

"This donation constitutes an important contribution to child medical care in Honduras," says Dr. Maynor Mata, President of APHCVS. "If performed in private hospitals, these surgeries could cost patients from U.S. $2,000 to U.S. $12,000. Now at Catarino Rivas, these operations are offered free of charge. Moreover, we look forward to using the new equipment to train the next generation of doctors in anesthesia and pediatric surgery, strengthening our healthcare system and securing the well-being of our future generations."

"Our donation to Mario Catarino Rivas Hospital underscores our commitment to improving access to healthcare for vulnerable populations, particularly children. We are privileged to partner with esteemed organizations like the Honduran Pediatric Association to make a meaningful difference in the lives of those in need," shared Benito Masi, President, Manufacturing at Gildan

This donation is part of Gildan's Next Generation ESG strategy, where the Company has committed to donate 1% of its pre-tax earnings towards purposeful community-driven projects by 2026. This donation marks an important step in Gildan's journey to bringing this goal to fruition and creating meaningful, long-term value in the regions where the Company operates.

For more information about Gildan's respect for communities, click here.

Gildan Donates Surgical Equipment to Mario Catarino Rivas Hospital

View additional multimedia and more ESG storytelling from Gildan Activewear on 3blmedia.com.

Contact Info:
Spokesperson: Gildan Activewear
Website: https://www.3blmedia.com/profiles/gildan-activewear
Email: info@3blmedia.com

SOURCE: Gildan Activewear



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.